Featured Stories
New stem cell partnership for CellBank
CellBank Australia has partnered with the European Bank for induced pluripotent Stem Cells (EBiSC) to enable our Oceania-based customers to access over 950 induced pluripotent stem cell (iPSC) lines representing over 45 different diseases. This includes gene-edited iPSC cells and pre-differentiated iPSC-Neurons. For over ten years, EBiSC has worked to enhance research outcomes by providing […]
We are excited to announce an exclusive Pilot Study Promotion at CMRI’s Single Cell Analytics Facility! From 12th August to 30th September, you can take advantage of this unique opportunity with no minimum sample requirement and receive preliminary bioinformatic analysis. Why Participate? Discover how Single Cell Transcriptomics can elevate your research by running a single […]
Organoids are mini-organs grown in the dish using 3D differentiation systems and have been shown to be an important tool in precision and regenerative medicine, as well as drug discovery research. When combined with the power of single cell transcriptomics, which enables transcriptomic information to be measured on thousands of single cells in a complex […]
A recent publication co-authored by CMRI’s Peptide Synthesis Facility’s Dr Md Musfizur Hassan, examined how nanoparticles can be used to predict the in vivo transport and drug delivery outcomes of various nanomedicine formulations across the blood brain barrier1. Nanoparticles are small particles (1-100nm) that are used for different clinical applications as a dosage form of […]
Working Towards Better Drug Delivery Systems for Chemotherapeutics A recent investigation by CMRI’s Peptide Facility Lead, Dr. Md Musfizur Hassan (1st author) and his collaborators at University of New South Wales and University of South Australia, explored the use of liposome-micelle-hybrid (LMH) carriers to enhance the delivery of the clinically relevant chemotherapeutics Paclitaxel (PTX) and […]
Subscribe for more news like this from CMRI Research Facilities
All News
Stay up to date with the latest when you subscribe.